Seattle Genetics

SGEN-Q

NASDAQ:SGEN

189.42
4.47 (2.41%)
Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer.
More at Wikipedia

Analysis and Opinions about SGEN-Q

Signal
Opinion
Expert
BUY
BUY
September 14, 2020

They have antibody-based cancer treatments that he feels Gilead just overpaid for today in an acquisition. Merck announced it would take a $1 billion stake in SGEN. SGEN stock jumped from $150 Friday to $171 today. SGEN has stalled in recent months, but turns out this was undervalued.

Show full opinionHide full opinion
Seattle Genetics (SGEN-Q)
September 14, 2020

They have antibody-based cancer treatments that he feels Gilead just overpaid for today in an acquisition. Merck announced it would take a $1 billion stake in SGEN. SGEN stock jumped from $150 Friday to $171 today. SGEN has stalled in recent months, but turns out this was undervalued.

Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Seattle Genetics(SGEN-Q) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for Seattle Genetics is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Seattle Genetics(SGEN-Q) Frequently Asked Questions

What is Seattle Genetics stock symbol?

Seattle Genetics is a American stock, trading under the symbol SGEN-Q on the NASDAQ (SGEN). It is usually referred to as NASDAQ:SGEN or SGEN-Q

Is Seattle Genetics a buy or a sell?

In the last year, 1 stock analyst published opinions about SGEN-Q. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is BUY. Read the latest stock experts' ratings for Seattle Genetics.

Is Seattle Genetics a good investment or a top pick?

Seattle Genetics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Seattle Genetics.

Why is Seattle Genetics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Seattle Genetics worth watching?

1 stock analyst on Stockchase covered Seattle Genetics In the last year. It is a trending stock that is worth watching.

What is Seattle Genetics stock price?

On 2020-09-28, Seattle Genetics (SGEN-Q) stock closed at a price of $189.415.